Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Babcock & Wilcox Enterprises (BWNB) Asset Writedowns and Impairment (2017 - 2025)

Babcock & Wilcox Enterprises' Asset Writedowns and Impairment history spans 5 years, with the latest figure at $9.9 million for Q4 2025.

  • For Q4 2025, Asset Writedowns and Impairment fell 6.79% year-over-year to $9.9 million; the TTM value through Dec 2025 reached $9.9 million, down 41.11%, while the annual FY2025 figure was $9.9 million, 3.66% up from the prior year.
  • Asset Writedowns and Impairment reached $9.9 million in Q4 2025 per BWNB's latest filing, up from -$587000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $56.6 million in Q4 2023 to a low of -$699000.0 in Q2 2024.
  • Average Asset Writedowns and Impairment over 3 years is $10.4 million, with a median of $3.5 million recorded in 2024.
  • The largest YoY upside for Asset Writedowns and Impairment was 6.79% in 2025 against a maximum downside of 110.12% in 2025.
  • A 3-year view of Asset Writedowns and Impairment shows it stood at $56.6 million in 2023, then plummeted by 81.27% to $10.6 million in 2024, then dropped by 6.79% to $9.9 million in 2025.
  • Per Business Quant, the three most recent readings for BWNB's Asset Writedowns and Impairment are $9.9 million (Q4 2025), -$587000.0 (Q3 2025), and $632000.0 (Q1 2025).